Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/07/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 784 publications
NuPOWER (Nuwiq for Perioperative management Of patients With haemophilia A on Emicizumab Regular prophylaxis): protocol for an open-label, single-arm, multicentre study.
Journal: BMJ open
Published: October 28, 2025
Outcomes of Emicizumab Treatment for Haemophilia A Paediatric Patients: A Systematic Review With Meta-Analysis.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: October 24, 2025
Laboratory Monitoring in Patients Receiving Emicizumab.
Journal: Hamostaseologie
Published: October 09, 2025
Laboratory Assessment of Emicizumab Levels in Hemophilia A: Influence of Assay Selection on Reported Results.
Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Published: September 26, 2025
Modelling US health equity impacts of emicizumab for severe haemophilia A: aggregate distributional cost-effectiveness analysis.
Journal: BMJ open
Published: September 10, 2025
Emicizumab in Acquired Hemophilia A: Benefits in Bleed Control, Safety, and Cost-Effectiveness.
Journal: Seminars in thrombosis and hemostasis
Published: September 09, 2025
From pharmacokinetic-guided FVIII prophylaxis to low-dose Emicizumab prophylaxis: a pilot study revealed a flush of hope.
Journal: Annals of hematology
Published: September 05, 2025
More real-world evidence on the impact of emicizumab.
Journal: Research and practice in thrombosis and haemostasis
Published: August 28, 2025
Assessment of emicizumab levels in EDTA plasma.
Journal: Research and practice in thrombosis and haemostasis
Published: August 22, 2025
Long-Term Joint Function and Quality of Life Following Emicizumab Prophylaxis in Severe Hemophilia A: A Single-Center Study From Goa, India.
Journal: Cureus
Published: August 22, 2025
NXT007 enhances in vitro coagulation potential in the coexistence of emicizumab in hemophilia A through distinct complex formation.
Journal: Research and practice in thrombosis and haemostasis
Published: August 21, 2025
Last Updated: 01/07/2026